Your browser doesn't support javascript.
loading
A Machine Learning Application Based in Random Forest for Integrating Mass Spectrometry-Based Metabolomic Data: A Simple Screening Method for Patients With Zika Virus.
Melo, Carlos Fernando Odir Rodrigues; Navarro, Luiz Claudio; de Oliveira, Diogo Noin; Guerreiro, Tatiane Melina; Lima, Estela de Oliveira; Delafiori, Jeany; Dabaja, Mohamed Ziad; Ribeiro, Marta da Silva; de Menezes, Maico; Rodrigues, Rafael Gustavo Martins; Morishita, Karen Noda; Esteves, Cibele Zanardi; de Amorim, Aline Lopes Lucas; Aoyagui, Caroline Tiemi; Parise, Pierina Lorencini; Milanez, Guilherme Paier; do Nascimento, Gabriela Mansano; Ribas Freitas, André Ricardo; Angerami, Rodrigo; Costa, Fábio Trindade Maranhão; Arns, Clarice Weis; Resende, Mariangela Ribeiro; Amaral, Eliana; Junior, Renato Passini; Ribeiro-do-Valle, Carolina C; Milanez, Helaine; Moretti, Maria Luiza; Proenca-Modena, Jose Luiz; Avila, Sandra; Rocha, Anderson; Catharino, Rodrigo Ramos.
Afiliação
  • Melo CFOR; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Navarro LC; RECOD Laboratory, Institute of Computing (IC), University of Campinas, Campinas, Brazil.
  • de Oliveira DN; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Guerreiro TM; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Lima EO; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Delafiori J; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Dabaja MZ; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Ribeiro MDS; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • de Menezes M; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Rodrigues RGM; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Morishita KN; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Esteves CZ; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • de Amorim ALL; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Aoyagui CT; Innovare Biomarkers Laboratory, School of Pharmaceutical Sciences (FCF), University of Campinas, Campinas, Brazil.
  • Parise PL; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • Milanez GP; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • do Nascimento GM; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • Ribas Freitas AR; Campinas Department of Public Health Surveillance, Campinas, Brazil.
  • Angerami R; São Leopoldo Mandic Institute and Research Center, Campinas, Brazil.
  • Costa FTM; Clinical Pathology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Arns CW; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • Resende MR; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • Amaral E; Clinical Pathology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Junior RP; Obstetrics and Gynecology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Ribeiro-do-Valle CC; Obstetrics and Gynecology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Milanez H; Obstetrics and Gynecology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Moretti ML; Obstetrics and Gynecology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Proenca-Modena JL; Clinical Pathology Department, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Avila S; Department of Genetics, Evolution, Microbiology and Immunology, Biology Institute, University of Campinas, Campinas, Brazil.
  • Rocha A; RECOD Laboratory, Institute of Computing (IC), University of Campinas, Campinas, Brazil.
  • Catharino RR; RECOD Laboratory, Institute of Computing (IC), University of Campinas, Campinas, Brazil.
Article em En | MEDLINE | ID: mdl-29696139
ABSTRACT
Recent Zika outbreaks in South America, accompanied by unexpectedly severe clinical complications have brought much interest in fast and reliable screening methods for ZIKV (Zika virus) identification. Reverse-transcriptase polymerase chain reaction (RT-PCR) is currently the method of choice to detect ZIKV in biological samples. This approach, nonetheless, demands a considerable amount of time and resources such as kits and reagents that, in endemic areas, may result in a substantial financial burden over affected individuals and health services veering away from RT-PCR analysis. This study presents a powerful combination of high-resolution mass spectrometry and a machine-learning prediction model for data analysis to assess the existence of ZIKV infection across a series of patients that bear similar symptomatic conditions, but not necessarily are infected with the disease. By using mass spectrometric data that are inputted with the developed decision-making algorithm, we were able to provide a set of features that work as a "fingerprint" for this specific pathophysiological condition, even after the acute phase of infection. Since both mass spectrometry and machine learning approaches are well-established and have largely utilized tools within their respective fields, this combination of methods emerges as a distinct alternative for clinical applications, providing a diagnostic screening-faster and more accurate-with improved cost-effectiveness when compared to existing technologies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2018 Tipo de documento: Article